Rna Diagnostics Inc.
PrivateLast Round
Grant
Feb 5, 2026
Total Funding Raised
$11.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rna Diagnostics Inc. is a molecular diagnostics company that has developed the Veridapt DX™ predictive biomarker platform to guide oncology treatment decisions by measuring tumor response to cancer drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rna Diagnostics Inc. Comparables
Compare Rna Diagnostics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomic Expression, Inc. | 81% | |
| MultiplexDX | 80% | |
| GeneCentric | 76% |
Rna Diagnostics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 5, 2026 | ||||
| Series A Extension | Sep 9, 2021 | ||||
| Series A | Nov 8, 2018 | ||||
| Angel | Aug 27, 2015 |
Rna Diagnostics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Bioscience Innovation Organization | Series A |
| BDC Capital | Series A Extension |
| iGan Partners | Series A, Series A Extension |
| Northern Ontario Heritage Fund Corporation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2026
$840K grant received from Northern Ontario Heritage Fund Corporation.
- Jul 4, 2025
Monthly visitors grew 143% MoM, reaching 1.1K.
Rna Diagnostics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rna Diagnostics Inc.'s valuation, stock price, and market status.
Is Rna Diagnostics Inc. a public or private company?
Rna Diagnostics Inc. is a private company.
What is the current stock price of Rna Diagnostics Inc.?
Rna Diagnostics Inc. is a private company, so its shares have no public market price. Caplight tracks Rna Diagnostics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rna Diagnostics Inc. worth (valuation)?
Valuation information for Rna Diagnostics Inc. is not publicly available.
Can I buy Rna Diagnostics Inc. stock?
Rna Diagnostics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rna Diagnostics Inc.'s last funding round?
Rna Diagnostics Inc.'s most recent funding round was Grant on February 5, 2026.
Who are the main investors in Rna Diagnostics Inc.?
Key investors in Rna Diagnostics Inc. include BDC Capital, iGan Partners.
Will Rna Diagnostics Inc. IPO soon?
No public IPO plans have been announced for Rna Diagnostics Inc..
How can I track Rna Diagnostics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Rna Diagnostics Inc.'s shares on secondary markets.